Jefferies' Picks For 2017's Most And Least Likely Biotech M&A Targets


Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


The total number of M&A deals dipped a bit in 2016, but total deal value surged 44 percent to $218.9 billion. With interest rates still historically low and the U.S. economy still firing on all cylinders, 2017 will likely be another strong year for M&A deals.

One sector that may be particularly ripe for buyouts is the discounted biotech sector, which had a tough year in 2016. With many of these stocks trading at a discount to where they were a year ago, biotech M&A interest may start to pick up soon.

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Jefferies analyst Brian Abrahams is cognizant of slowing volumes and increasing competition in the space, but he still believes that there will be plenty of biotech deals this year.

“We see a stabilizing political backdrop and increasingly pro-industry regulatory environment offsetting some of the negativity, and believe an uptick in M&A should catalyze momentum particularly for mid-caps and help improve mixes sentiment,” Abrahams explains.

A survey of buy-side investors found that the most likely biotech buyout targets in 2017 are Incyte Corporation (NASDAQ: INCY), TESARO Inc (NASDAQ: TSRO) and Actelion Ltd (OTC: ALIOF).

The survey suggests the least likely biotech M&A targets include Gilead Sciences, Inc. (NASDAQ: GILD), Intercept Pharmaceuticals Inc (NASDAQ: ICPT) and Ionis Pharmaceuticals Inc (NASDAQ: IONS).


Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


Posted In: Analyst ColorBiotechLong IdeasNewsM&AAnalyst RatingsTrading IdeasGeneralBrian AbrahamsJefferies